Filing Details

Accession Number:
0001209191-16-121774
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-19 17:21:42
Reporting Period:
2016-05-17
Filing Date:
2016-05-19
Accepted Time:
2016-05-19 17:21:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
742112 Invacare Corp IVC Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 952680965
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1314132 C Dale Laporte One Invacare Way
Elyria OH 44035
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2016-05-17 375 $10.33 35,697 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 20,000 Indirect By Trust
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Shares Stock Option (Right to Buy) $0.00 7,858 7,858 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
7,858 7,858 Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of covering tax obligations arising in connection with the vesting of restricted shares.
  2. Includes an aggregate of 9,932 restricted stock units issued pursuant to the Invacare Corporation 2013 Equity Compensation Plan.
  3. Owned by the Reporting Person's Rollover IRA.
  4. No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
  5. The reporting person holds previously reported options to buy 7,858 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted on February 12, 2009, at an exercise price of $19.09 per share, will expire on February 12, 2019, and became exercisable between March 31, 2010 and March 31, 2013.